3.15
-0.10 (-3.11%)
| Penutupan Terdahulu | 3.25 |
| Buka | 3.23 |
| Jumlah Dagangan | 180,739 |
| Purata Dagangan (3B) | 102,892 |
| Modal Pasaran | 1,498,178,560 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2025 |
| Margin Keuntungan | -142.87% |
| Margin Operasi (TTM) | -37.77% |
| EPS Cair (TTM) | -4.26 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 485.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 111.40% |
| Nisbah Semasa (MRQ) | 0.570 |
| Aliran Tunai Operasi (OCF TTM) | -312.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -241.91 M |
| Pulangan Atas Aset (ROA TTM) | -26.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (GB) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | IDORSIA LTD IDORSIA N ORD SHS | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | -0.38 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| IDORSIA LTD IDORSIA N ORD SHS | 1 B | - | - | - |
| RELIEF THERAPEUTICS HOLDING SA | 2 B | - | - | 1.08 |
| OXFORD NANOPORE TECHNOLOGIES PL | 1 B | - | - | 2.30 |
| IOVANCE BIOTHERAPEUTICS INC IOV | 304 M | - | - | - |
| PURETECH HEALTH PLC ORD 1P | 292 M | - | 9.31 | 1.07 |
| FARON PHARMACEUTICALS OY ORD NP | 231 M | - | - | 165.73 |
|
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 30.75% |
| % Dimiliki oleh Institusi | 15.64% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |